2,9-Diaminoanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone, 98%, 1g

[2,2':6',2''-terpyridine]-4'-carbaldehyde, 97%, 1g

4-(Benzylamino)-2-((3-chloro-4-hydroxyphenethyl)amino)pyrimidine-5-carboxamide, 95.0%, 5mg

1-(Tetrahydro-2H-pyran-2-yl)-1H-indazol-4-amine, 95.0%, 250mg

Etoxilato de propileno, min 98%, para síntesis, 1L, envase de vidrio

3-((3S,4S)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE, 95%, 10mg

Tetrahydro-2H-thiopyran-3-carboxylic acid, 95.0%, 500mg

5-Bromo-1H-pyrazolo[4,3-b]pyridine, 95.0%, 250mg

5-(2-Methoxyethoxy)pyrazine-2-carboxylic acid, 1g

4-Chloro-1H-indazol-5-ol, 95.0%, 1g

trans,trans-4-[(E)-1-Propenyl]-4'-propylbicyclohexyl>98.0%(GC)5g

PLANTAMAJOSIDE, 98%, 50mg

(S)-6-Methylchroman-4-amine hydrochloride, 95.0%, 1g